Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
4.170
-0.110 (-2.57%)
Nov 21, 2024, 4:00 PM EST - Market closed

Skye Bioscience Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-21.24-37.64-19.48-8.52-6.561.05
Upgrade
Depreciation & Amortization
0.150.120.110.0300
Upgrade
Other Amortization
0.830.330.490.590.540.63
Upgrade
Loss (Gain) From Sale of Assets
-1.210.3----
Upgrade
Asset Writedown & Restructuring Costs
21.5421.22----
Upgrade
Stock-Based Compensation
6.820.990.630.870.30.68
Upgrade
Other Operating Activities
-25.931.26.27-0.1-0.44-8.69
Upgrade
Change in Accounts Payable
-0.85-0.70.80.520.240.13
Upgrade
Change in Other Net Operating Assets
-1.020.23-1.560.13-0.150.16
Upgrade
Operating Cash Flow
-20.91-13.95-12.74-6.47-6.05-6.03
Upgrade
Capital Expenditures
-1.56-0.01-0.09-0.09-0.01-
Upgrade
Sale of Property, Plant & Equipment
1.225.53----
Upgrade
Cash Acquisitions
-1.085.31---
Upgrade
Investing Cash Flow
-0.346.65.21-0.09-0.01-
Upgrade
Short-Term Debt Issued
-4.97----
Upgrade
Long-Term Debt Issued
--0.68-0.573.99
Upgrade
Total Debt Issued
-4.970.68-0.573.99
Upgrade
Long-Term Debt Repaid
--0.26-0.89---3.99
Upgrade
Net Debt Issued (Repaid)
-0.024.71-0.21-0.570.01
Upgrade
Issuance of Common Stock
83.8212014.016.996.08
Upgrade
Other Financing Activities
-0.27-0.27--0.94-0.85-0.08
Upgrade
Financing Cash Flow
83.5316.44-0.2113.086.76
Upgrade
Net Cash Flow
62.289.09-7.746.510.64-0.02
Upgrade
Free Cash Flow
-22.47-13.96-12.84-6.57-6.06-6.03
Upgrade
Free Cash Flow Per Share
-0.76-1.99-5.78-4.04-6.55-8.89
Upgrade
Cash Interest Paid
0.20.20.330.040.120.37
Upgrade
Cash Income Tax Paid
000.01000
Upgrade
Levered Free Cash Flow
-15.71-10.91-9.44-3.28-3.81-18.49
Upgrade
Unlevered Free Cash Flow
-15.52-10.67-9.51-3.39-3.91-18.5
Upgrade
Change in Net Working Capital
6.183.32-1.29-0.70.2815.03
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.